These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group. Japour AJ; Mayers DL; Johnson VA; Kuritzkes DR; Beckett LA; Arduino JM; Lane J; Black RJ; Reichelderfer PS; D'Aquila RT Antimicrob Agents Chemother; 1993 May; 37(5):1095-101. PubMed ID: 8517697 [TBL] [Abstract][Full Text] [Related]
28. In vitro effects of anti-HIV immunotoxins directed against multiple epitopes on HIV type 1 envelope glycoprotein 160. Pincus SH; Wehrly K; Cole R; Fang H; Lewis GK; McClure J; Conley AJ; Wahren B; Posner MR; Notkins AL; Tilley SA; Pinter A; Eiden L; Teintze M; Dorward D; Tolstikov VV AIDS Res Hum Retroviruses; 1996 Jul; 12(11):1041-51. PubMed ID: 8827220 [TBL] [Abstract][Full Text] [Related]
29. Chemotherapeutic options in HIV infection. Cox S; Palmer S; Aperia K; Wahren B Adv Exp Med Biol; 1994; 370():443-51. PubMed ID: 7660948 [No Abstract] [Full Text] [Related]
30. Susceptibilities of zidovudine-susceptible and -resistant human immunodeficiency virus isolates to antiviral agents determined by using a quantitative plaque reduction assay. Larder BA; Chesebro B; Richman DD Antimicrob Agents Chemother; 1990 Mar; 34(3):436-41. PubMed ID: 2334156 [TBL] [Abstract][Full Text] [Related]
31. Rationale for the use of immunotoxins in the treatment of HIV-infected humans. Van Oijen MG; Preijers FW J Drug Target; 1998; 5(2):75-91. PubMed ID: 9588864 [TBL] [Abstract][Full Text] [Related]
32. Cloning and expression of the gene coding for IL-2(60)-PE40, a molecular targeted protein. Zhang M; Zhao X; Li H; Lu S Chin Med Sci J; 1995 Sep; 10(3):136-40. PubMed ID: 8580481 [TBL] [Abstract][Full Text] [Related]
33. Relative inefficiency of soluble recombinant CD4 for inhibition of infection by monocyte-tropic HIV in monocytes and T cells. Gomatos PJ; Stamatos NM; Gendelman HE; Fowler A; Hoover DL; Kalter DC; Burke DS; Tramont EC; Meltzer MS J Immunol; 1990 Jun; 144(11):4183-8. PubMed ID: 2341717 [TBL] [Abstract][Full Text] [Related]
34. Resistance of human immunodeficiency virus type 1 to antiretroviral agents: a review. Erice A; Balfour HH Clin Infect Dis; 1994 Feb; 18(2):149-56. PubMed ID: 7512829 [No Abstract] [Full Text] [Related]
35. Susceptibility testing by polymerase chain reaction DNA quantitation: a method to measure drug resistance of human immunodeficiency virus type 1 isolates. Eron JJ; Gorczyca P; Kaplan JC; D'Aquila RT Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3241-5. PubMed ID: 1565615 [TBL] [Abstract][Full Text] [Related]
36. Soluble CD4 enhances the efficacy of immunotoxins directed against gp41 of the human immunodeficiency virus. Pincus SH; McClure J Proc Natl Acad Sci U S A; 1993 Jan; 90(1):332-6. PubMed ID: 8419938 [TBL] [Abstract][Full Text] [Related]
37. Drug combinations and effect parameters of zidovudine, stavudine, and nevirapine in standardized drug-sensitive and resistant HIV type 1 strains. Zhu QY; Scarborough A; Polsky B; Chou TC AIDS Res Hum Retroviruses; 1996 Apr; 12(6):507-17. PubMed ID: 8679306 [TBL] [Abstract][Full Text] [Related]
38. Additional mutations detected in sequential HIV-1 isolates from ZDV-treated patients. Magierowska-Jung M; Agut H; Katlama C; Autran B; Huraux JM J Med Virol; 1997 Jan; 51(1):48-55. PubMed ID: 8986949 [TBL] [Abstract][Full Text] [Related]
39. Development and significance of zidovudine resistance in children infected with human immunodeficiency virus. Ogino MT; Dankner WM; Spector SA J Pediatr; 1993 Jul; 123(1):1-8. PubMed ID: 8100579 [TBL] [Abstract][Full Text] [Related]
40. Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS. Land S; Terloar G; McPhee D; Birch C; Doherty R; Cooper D; Gust I J Infect Dis; 1990 Feb; 161(2):326-9. PubMed ID: 2299212 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]